Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature.
Τίτλος | Safety of Ferric Carboxymaltose in Children: Report of a Case Series from Greece and Review of the Literature. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Panagopoulou, P., Alexiadou S., Ntoumpara M., Papazoglou A., Makis A., Tragiannidis A., Fotoulaki M., & Mantadakis E. |
Journal | Paediatr Drugs |
Volume | 24 |
Issue | 2 |
Pagination | 137-146 |
Date Published | 2022 Mar |
ISSN | 1179-2019 |
Λέξεις κλειδιά | Adult, Child, Ferric Compounds, Greece, Humans, Maltose, Prospective Studies |
Abstract | BACKGROUND: Parenteral iron is generally considered safe in adults, and severe adverse events are extremely rare. Ferric carboxymaltose (FCM), a third-generation parenteral iron product, is not licensed for pediatric use. |
DOI | 10.1007/s40272-022-00491-5 |
Alternate Journal | Paediatr Drugs |
PubMed ID | 35083718 |
PubMed Central ID | 4111808 |